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Abstract
Since the opportunistic pathogen Pneumocystis carinii grows only slowly in vitro, the mechanism of glucose uptake was
investigated to better understand how the organism transports nutrients. Using the non-metabolizable analogue 2-
deoxyglucose, two uptake systems were detected with Q10 values of 2.12 and 2.09, respectively. One had a high affinity
(Km = 67.5 WM) and the other a low affinity (Km = 5.99 mM) for 2-deoxyglucose uptake. Glucose or deoxyglucose phosphate
products from transported radiolabeled substrates were not detected during the incubation times used in this study. Both
systems were inhibited by mannose, galactose, fructose, galactosamine, glucosamine, and glucose but not by allose, 5-
thioglucose, xylose, glucose 6-phosphate and glucuronic acid. Salicylhydroxamate, KCN, iodoacetate, and 2,4-dinitrophenol
inhibited the high-affinity transporter, suggesting it required ATP. Ouabain, monensin, carbonyl cyanide m-chlorophe-
nylhydrazone, and N,NP-dicyclohexylcarbodiimide also inhibited deoxyglucose uptake, as did the replacement of Na in the
incubation medium with choline, indicating requirements for Na and H. The high-affinity system was also inhibited by the
protein synthesis inhibitors cycloheximide and chloramphenicol. In contrast, the low-affinity system transported
deoxyglucose by facilitated diffusion mechanisms. Unlike the human erythrocyte glucose transporter GLUT1, the P. carinii
transporters recognized fructose and galactose and were relatively insensitive to cytochalasin B, suggesting that the P. carinii
glucose transporters may be good drug targets. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pneumocystis carinii is an opportunistic eukaryotic
pathogen of the lungs that can be found in mammals
lacking disease symptoms, but it also can be respon-
sible for major morbidity and mortality in those with
defective immune systems. In immunode¢cient hosts,
the organism can grow rapidly in the lung alveolus
where it causes in£ammation, major damage to the
alveolar epithelium and blocks exchange of gases be-
tween the alveolar lumen and blood capillaries. Ef-
fective chemotherapeutic treatment available to pre-
vent or clear P. carinii pneumonia (PcP) includes
trimethoprim/sulfamethoxazole (TMP/SMX), trime-
trexate, pentamidine and atovaquone. However,
these can cause severe side e¡ects in some patients
[1]. Membrane transport processes represent poten-
tial targets for drug development, since it is by these
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mechanisms that the organism imports vital nu-
trients. Blocking normal nutrient uptake may result
in clearing the infection caused by these organisms.
The organism proliferates extracellularly bathed by
£uid rich in lung surfactant secreted by alveolar type
II epithelial cells. Approx. 90% of lung surfactant is
lipids with lower amounts of proteins and carbohy-
drates. In contrast to growth in the lung, organisms
placed in axenic culture [2,3] or co-cultivated with
mammalian cells [4,5] multiply only very slowly,
and most P. carinii culture protocols do not sustain
long-term passage and proliferation in vitro [6]. Be-
cause of slow growth in vitro, much of the organ-
ism’s basic biochemistry has yet to be examined. Per-
forming biochemical experiments on P. carinii are
not trivial but they can be done. Most studies have
been done using puri¢ed organisms isolated from
immunosuppressed animal models.
Glucose is a nutrient that serves as an important
carbon source in prokaryotic and eukaryotic organ-
isms. Organisms satisfy their requirement for this
sugar by synthesizing it, hydrolyzing glucose-contain-
ing complex molecules such as glycogen, or by ac-
quiring it from exogenous sources. That glucose is a
major structural precursor in the organism is sug-
gested by the identi¢cation of this sugar as the dom-
inant monosaccharide component of the P. carinii
cyst wall [7], and the high 1,3-L-glucan synthetase
activity measured by the incorporation of [14C]-
UDP-glucose into cell wall L-glucans [8]. [14C]-
Glucose utilization via the classic aerobic glycolytic
pathway to produce 14CO2 was reported [9], but the
purity of the organism preparations used for that
earlier study was not de¢ned. Recently, it was found
that P. carinii requires glucose for axenic growth in
vitro; 1^5.5 mM glucose sustained culture growth
over 3 weeks, whereas cell proliferation was not ob-
served without glucose (Clarkson, A.B., Jr., Merali,
S., pers. commun.).
Glucose transport systems have been studied in
many prokaryotic and eukaryotic cells [10^29]. In
most mammalian cells, the rate of glucose metabo-
lism is limited by the transport of exogenous glucose
across the plasma membrane. The mechanism of glu-
cose uptake most commonly encountered is by fa-
cilitated transport via glucose-speci¢c translocation
systems described as carriers, transporters, or per-
meases. Both facilitated di¡usion [15^19] and active
transport for glucose uptake have been identi¢ed.
Co-transport (linked transport, coupled transport)
requiring speci¢c ions such as Na [20^22] or H
[11,23^29] for symport translocation of glucose has
been characterized. Although glucose transporter
systems are among the most studied among di¡erent
cell types, there is only little information on the
mechanism of glucose transport in P. carinii. In the
present study, we analyzed the uptake by P. carinii of
radiolabeled glucose and the non-metabolizable
analogue 2-deoxy-D-glucose (2-DOG).
2. Materials and methods
2.1. Chemicals
D-[U-14C]Glucose (10 mCi/mmol, s 99% purity)
was obtained from ARC (St. Louis, MO, USA).
2-Deoxy-D-[2,6-3H]glucose (44 Ci/mmol, 1 mCi/ml)
was purchased from Amersham Pharmacia Biotech
(Piscataway, NJ, USA). The radiochemical purity
determined by HPLC was 96.8% and the distribution
of the label was 51.8% and 48.2% for the H-2 and H-
6 position, respectively. All other compounds includ-
ing unlabeled D-hexose sugars, glucose analogues, in-
hibitors and bovine serum albumin were of the high-
est quality available from Sigma-Aldrich (St. Louis,
MO, USA). D-Galactose (s 99%) was from Sigma-
Aldrich or Acros Organics (Pittsburgh, PA, USA). 5-
Thio-D-glucose was from ICN (Costa Mesa, CA,
USA), and sodium azide and potassium cyanide
(KCN) were from Fisher Scienti¢c (Pittsburgh, PA,
USA).
2.2. Organisms
P. carinii f. sp. carinii was isolated from the lungs
of corticosteroid-immunosuppressed rats with PcP
[30,31]. Viral antibody-negative female Lewis rats
(Harlan Sprague^Dawley, Indianapolis, IN, USA)
were immunosuppressed with methylprednisolone
acetate (Depo-Medrol; Upjohn, Kalamazoo, MI,
USA) and were twice inoculated intratracheally
with 106^107 mixed life cycle stages of cryopreserved
organisms [31]. Lung homogenates containing P. ca-
rinii that were used for inoculation into the rats were
prepared under aseptic conditions in the absence of
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antibiotics [31]. Aliquots of these preparations were
cryopreserved and only those that tested negative for
common bacteria (Mueller Hinton agar, Difco, De-
troit, MI, USA) and fungi (Sabouraud dextrose agar,
Difco) were used for infecting rats. After 8^10 weeks
of immunosuppression, moribund rats were killed
and their lungs were perfused, excised, and cut into
small pieces.
The organisms were isolated and puri¢ed by pro-
cedures previously described [31]. Brie£y, lung pieces
were homogenized (Stomacher; Tekmar, Cincinnati,
OH, USA) with the mucolytic sulfhydryl agent glu-
tathione (reduced form), which caused the detach-
ment of organisms from host cells and other P. ca-
rinii organisms. Puri¢cation involved sieving and a
series of centrifugation steps at di¡erent speeds, fol-
lowed by membrane micro¢ltration. The purity of
the organism preparations was documented by mi-
croscopic, biochemical, immunochemical, and micro-
biological analyses, all of which indicated s 95^
100% purity [31,32].
These preparations contained 10^30% cystic
forms. The percentage of viable organisms in the
preparations was conservatively estimated between
80% and 95% by the £uorescence dual staining assay
[31]. Process control pellets resulting from subjecting
the lungs of a single normal, untreated rat or an
immunosuppressed, uninfected rat to the same isola-
tion and puri¢cation protocol did not produce visible
pellets after the ¢nal centrifugation step. The highest
(not average) total protein remaining in the centri-
fuge tube was 6 300 Wg (n = 10) [31]. In contrast, the
volume of P. carinii packed pellets puri¢ed from a
single infected rat (108^109 organisms) was 0.3^0.4
ml, containing approx. 5 mg protein [31].
2.3. Uptake of glucose and 2-DOG
Organisms (108^109) were centrifuged at 926Ug
for 10 min at 4‡C and then the pellet was resus-
pended at a density of approx. 5U107 cells/ml of a
HEPES-bu¡ered solution (100 mM HEPES, 1.8 mM
CaCl2, 145 mM NaCl) at pH 7.4. Uptake of D-[U-14C]-
glucose was performed by incubating organisms with
0.5 WCi of the radiocompound plus various con-
centrations of non-radioactive glucose in a ¢nal vol-
ume of 0.8 ml incubation solution. Uptake of de-
oxyglucose (1 WCi of 2-[2,6-3H]DOG) and analyses
of the e¡ects of various sugars or inhibitors were per-
formed by adding various concentrations of the com-
pounds to the organism suspensions. After 1 min
incubation at 37‡C, uptake was terminated by the
addition of 2 ml of ice-cold HEPES-bu¡ered solution
supplemented with 100 mM glucose or 2-DOG, and
high-speed centrifugation (3000Ug) at 4‡C for 2 min.
The supernatant was aspirated, and then 5 ml of ice-
cold HEPES-bu¡ered solution were carefully layered
over the pellet without disrupting the pellet or resus-
pending the cells. The sample was then subjected to
centrifugation for 1 min, the supernatant removed,
and then the radioactivity in the resultant pellet was
measured by liquid scintillation counting (e⁄ciencies
were 45% and 94% for 3H and 14C, respectively).
Alternatively, the organisms in pellets were resus-
pended and washed with the ice-cold HEPES-bu¡-
ered solution, and then centrifuged. The two proto-
cols for removing excess extracellular radioactive
compounds gave the same results. The equivalent
results were attributed to the small size of the cell
pellets, i.e. insigni¢cant amounts of radioactive incu-
bation medium were trapped in between organisms
in the ¢nal pelleted material.
To analyze the e¡ects of various inhibitor com-
pounds and ionophores, the organisms were preincu-
bated at 37‡C with the compound for 10 min prior to
the initiation of 2-DOG uptake analysis. The protein
concentration of cells was measured by the method
of Lowry et al. [33] with bovine serum albumin as
standard. 2-DOG uptake rates were expressed as
nmol or pmol of 2-DOG/mg of P. carinii total pro-
teins/min. Estimates of cell volume (cysts, 32.6 £;
trophozoites, 94.7 £), an average of 20% cysts in
the preparation, and an estimate of 1 mg protein of
the preparation represents 2.6U108 organisms, were
taken from previously reported analyses [31].
2.4. Phosphorylated glucose
After intact cells had been incubated with radio-
labeled glucose or 2-DOG for 1 min, incorporation
into hexose phosphates was examined. Protein and
nucleic acid macromolecules were precipitated by
adding 0.2 ml of 5.6% (w/v) perchloric acid to the
cell pellet, and after centrifugation, the phosphory-
lated compounds in the soluble fraction were precipi-
tated with ZnSO4 and Ba(OH)2 according to the
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procedure described by Somogyi [34]. Brie£y, after
neutralization and centrifugation, 0.25 ml 0.15 M
ZnSO4, and then 0.25 ml 0.15 M Ba(OH)2 were
added to the supernatant fraction. After 5 min at
room temperature, the suspension was centrifuged,
and then the resultant pellet and supernatant frac-
tions were analyzed for radioactivity. Samples not
treated by ZnSO4 and Ba(OH)2 precipitation to
which 0.5 ml of H2O was added, served as controls.
2.5. Data analyses
Uptake was analyzed using the software program
Gra¢t (version 4.0.12, Erithacus Software, Sigma).
Statistical analyses (n = 3) were performed using Mi-
crosoft Excel 2000. The Km and Vmax values were
determined by linear transformation of the Michae-
lis^Menten equation using the Eadie^Hofstee plot,
and the method of Spears et al. [35] for demonstrat-
ing the presence of two independent transporter sys-
tems. The temperature coe⁄cient (Q10), which repre-
sents the increase in velocity (k) observed when the
temperature is raised by 10‡C, was calculated by the
van ’t Ho¡ equation: Q10 = (k2/k1)10=t23t1.
3. Results
3.1. Uptake of glucose
The initial uptake rate of the natural substrate
glucose was measured over a 1 min period using
di¡erent external glucose concentrations from 1 mM
to 50 mM. Uptake of radiolabeled glucose appeared
to re£ect ¢rst order kinetics (Fig. 1A,B), indicating
that glucose uptake by P. carinii was carrier-medi-
ated. It is assumed that glucose acquired exogenously
by the organism is metabolized; nonetheless, glucose
uptake appeared linear up to 5 mM, and saturation
was observed at approx. 20 mM. The apparent Km
was estimated at 5.2 þ 0.5 mM and the apparent Vmax
was 3560 þ 106 pmol/mg of total P. carinii protein/
min.
3.2. Kinetics of 2-DOG uptake
The glucose analogue 2-DOG was then employed
to investigate the mechanism of glucose uptake by
P. carinii in greater detail. The time course of 100 WM
and 10 mM 2-DOG accumulation in P. carinii was
studied using incubation times from 1 min to 30 min
(Fig. 1C). The initial rate was approximately linear
up to 10 min for both substrate concentrations. After
30 min incubation, the levels of 2-DOG in the cells
reached a plateau between 13 and 15 nmol/mg pro-
tein when extracellular 2-DOG concentration was
100 WM, whereas a plateau was seen at a higher
intracellular 2-DOG content of 63^65 nmol/mg pro-
tein when extracellular 2-DOG concentration was 10
mM. It was estimated that intracellular 2-DOG con-
centrations under the two incubation conditions after
30 min were 1.1^1.3 mM and 5.4^5.5 mM, respec-
tively (calculated using the average percentage of
cysts in the preparations and the known volumes
and protein content of the cells). Uptake against a
concentration gradient was evident only when low
(100 WM) extracellular 2-DOG was used. The obser-
vations suggest that glucose is translocated across the
cell surface membrane by active transport (evident at
low extracellular 2-DOG concentration) and that ad-
ditional amounts can enter the cells (at high extra-
cellular 2-DOG concentration) via a separate mech-
anism, e.g. facilitative di¡usion.
Initial uptake rates of 2-DOG were determined for
1 min at various external 2-DOG concentrations
from 0.029 WM to 50 mM. The process exhibited ¢rst
order kinetics; saturation occurred at approx. 20
mM 2-DOG (Fig. 1D). The kinetics of 2-DOG up-
take was comparable to that of the natural substrate
glucose (Fig. 1A,B), indicating that 2-DOG was an
appropriate analogue to study the mechanism of glu-
cose uptake by P. carinii. The Eadie^Hofstee plot of
the data showed two straight lines, which suggests
that the organism had two independent transport
systems for glucose uptake (Fig. 1C). The Km values
were 67.5 þ 2.5 WM and 5.99 þ 0.21 mM for the high-
and low-a⁄nity system, respectively. The Vmax values
were 237 þ 22 pmol/mg protein/min and 3035 þ 70
pmol/mg protein/min, respectively. The kinetic pa-
rameters of the low-a⁄nity, high-capacity 2-DOG
transporter system were similar to the values ob-
tained using 1^50 mM glucose in the initial experi-
ments that were performed testing whether 2-DOG
and glucose were equivalent as substrates taken up
by P. carinii.
The e¡ect of temperature on 2-DOG uptake was
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examined by placing P. carinii suspensions at 4‡C
and comparing the rates measured with those ob-
tained at 37‡C (controls). Uptake was reduced at
4‡C; 2-DOG uptake by the high-a⁄nity transporter
was only 6.1 þ 2.8% of control, and uptake by the
low-a⁄nity was 6.9 þ 2.5% of control. The Q10 values
calculated were 2.12 and 2.09, respectively, both of
which are typical for carrier-mediated transport.
Fig. 1. Kinetics of glucose and 2-DOG initial uptake rates in P. carinii. (A) Uptake of glucose at various substrate concentrations.
Points are means þ S.E.M.; n = 3. (B) Double reciprocal plot of the glucose uptake. (C) Uptake of 2-DOG measured as a function of
time using substrate concentrations of 100 WM (circles) and 10 mM (squares). Closed and open symbols represent two independent ex-
periments. (D) Rate of 2-DOG uptake at various substrate concentrations measured at 37‡C for 1 min. Saturation was observed at
approx. 20 mM 2-DOG, similar to that of glucose uptake shown in A. Thus, this analogue is an appropriate compound for studying
the glucose transporter systems in P. carinii. Each point represents the means þ S.E.M. of three separate experiments. (E) Eadie^Hof-
stee plots of 2-DOG uptake data shown in D demonstrating the presence of two transporter systems (two di¡erent slopes).
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3.3. Substrate speci¢city of the glucose transport
systems
Uptake by the high-a⁄nity and the low-a⁄nity
systems was measured using a substrate concentra-
tion of 100 WM and 10 mM 2-DOG, respectively,
and the e¡ects of various hexose sugars and ana-
logues were tested. In the presence of a 10-fold excess
of various sugars 2-DOG uptake was strongly inhib-
ited by glucose (Table 1), indicating that glucose and
2-DOG are both taken up by P. carinii via the same
transporters. Strong inhibition occurred with man-
nose (92^96% inhibition of the high-a⁄nity system;
56^75% inhibition of the low-a⁄nity system). This
suggests that the hydroxyl group at the C-2 position
of the sugar is not essential for recognition by the
transporters, but it may have an in£uence on the
function of the low-a⁄nity system. Lower levels of
inhibition (approx. 50%) of 2-DOG uptake by galac-
tose, the 4-epimer of glucose, was observed. By in-
creasing the ratio of galactose/2-DOG by 100, the
high- and low-a⁄nity systems were inhibited by
70 þ 2% and 65 þ 3%, respectively. These results
may indicate that the hydroxyl group at the C-4
position is involved in the recognition of sugars by
the transporter. Fructose also inhibited both systems
by half when this sugar was present in a fructose/2-
DOG ratio of 10 (Table 1). With an increased ratio
of 100, the high- and low-a⁄nity systems were inhib-
ited by 66 þ 4% and 71 þ 3%, respectively. The IC50
for fructose inhibition of 2-DOG uptake was esti-
mated at approx. 1 mM. Glucosamine and galactos-
amine were less e¡ective than glucose and galactose,
respectively, indicating that the transporters pre-
ferred substrate analogues lacking charged amino
groups, and that the oxygen in the C-2 position,
like that in glucose, was an important structural fea-
ture recognized by the transporter systems.
The analogue 5-thioglucose did not inhibit either
transport system (Table 1). Using a ratio of 100
times, an only 25% and 23% inhibition of the high-
and low-a⁄nity transport system, respectively, was
observed. These data indicate that the ring oxygen
is an essential requirement for binding to the carrier,
probably involving hydrogen bonds. Allose, glucur-
onic acid, glucose 6-phosphate, and xylose did not
inhibit either of the 2-DOG uptake systems (Table
1). The same results were obtained by increasing the
ratio of analogue/2-DOG by 100 (data not shown).
The lack of interaction between transporters and
these compounds suggests that the C-3 and C-6 hy-
droxyl group con¢gurations as found in glucose are
Table 1
E¡ect of D-glucose analogues and disaccharides on the two 2-DOG uptake systems in P. carinii
Oxygen function Hexose substrate/analogue 2-DOG transport (% of control)
High-a⁄nity system Low-a⁄nity system
Monosaccharides
C-2 Glucose 3.8 þ 1.4 25 þ 4
Glucosamine 42 þ 7 46 þ 5
Mannose 6.2 þ 1.1 34 þ 9
C-3 Allose 81 þ 2 91 þ 4
C-4 Galactose 49 þ 2 54 þ 4
Galactosamine 68 þ 7 71 þ 2
C-5 5-Thioglucose 95 þ 2 97 þ 3
C-6 Fructose 57 þ 2 54 þ 3
Glucuronic acid 90 þ 6 92 þ 3
Glucose 6-phosphate 84 þ 1 87 þ 3
Xylose 87 þ 1 88 þ 6
Disaccharides
Lactose 82 þ 1 159 þ 5
Maltose 77 þ 1 83 þ 5
Sucrose 94 þ 10 93 þ 1
Transport of 100 WM (high-a⁄nity system) and 10 mM (low-a⁄nity system) 2-DOG was determined at pH 7.4 for 1 min in the pres-
ence of competitors (10-fold excess). Control uptake rates of 2-DOG by the two systems were 245 þ 5 and 3015 þ 21 pmol/mg protein/
min, respectively. Percent of control values are expressed as means þ S.E.M. of three independent experiments.
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essential structural features. Also, since glucose 6-
phosphate and glucuronic acid are both charged at
pH 7.4, the absence of e¡ect of these compounds on
2-DOG uptake by P. carinii indicates that a negative
charge at the C-6 region of the substrate prevents
binding with the carriers.
The disaccharides lactose (galactose L (1,4), glu-
cose), maltose (glucose K (1,4), glucose) and sucrose
(glucose K (1,2), L fructose) did not inhibit either of
the 2-DOG uptake systems (Table 1). The same re-
sults were obtained by increasing the ratio of disac-
charide/2-DOG for both systems to 100 (data not
shown). These results showed that the transporter
is speci¢c for monosaccharides.
It was previously shown that uptake of the amino
acid serine by P. carinii required the presence of glu-
cose in the medium [36]. To examine whether this
was due to co-transport of the amino acid with glu-
cose, the e¡ects of 1 mM and 100 mM serine on 2-
DOG uptake were tested. Serine did not stimulate or
inhibit 2-DOG uptake by the organism; uptake by
the high-a⁄nity system was 89 þ 6% of control with-
out serine, and uptake by the low-a⁄nity system was
91 þ 3% of control. The same results were obtained
when serine was increased to 100-fold excess over
that of 2-DOG using 10 mM and 1 M serine for
the high- and low-a⁄nity system, respectively (data
not shown). The e¡ect of serine on glucose uptake
was examined to determine whether the lack of e¡ect
of this amino acid on 2-DOG uptake was related to
di¡erences in structure of the natural substrate and
the non-metabolizable analogue. Uptake of 5 mM
radiolabeled glucose was not altered by the presence
of 5 mM, 50 mM or 100 mM exogenous serine.
Compared to controls lacking exogenous serine, up-
takes were 97 þ 4%, 116 þ 4% and 95 þ 5%, respec-
tively.
3.4. Analysis of phosphorylated substrates
In some cells, glucose uptake involves a cell sur-
face membrane hexokinase activity that phosphory-
lates the substrate as part of the translocation pro-
cess. Using 5 mM radiolabeled glucose (1 WCi), or 10
WM or 100 WM radiolabeled 2-DOG (1 WCi) at pH
7.4 for 1 min the soluble fraction of P. carinii cells
was analyzed for phosphorylated products that were
isolated by precipitation. Radioactivity in the phos-
phorylated glucose or 2-DOG pelleted material was
not detected. Increasing the radioactivity of the sub-
strate to 5 WCi did not result in detectable radiola-
beled hexose phosphates. In two separate experi-
ments using 5 WCi 2-DOG, 99.9% and 91.6% of the
radioactivity were in the supernatant. Likewise, using
5 WCi glucose, 98.7% and 96.3% of the radioactivity
were in the supernatant. These results indicated that
putative glucose or 2-DOG phosphates produced
from exogenous radiolabeled hexoses were undetect-
able under the experimental conditions used in this
study, and suggest that the glucose transport process
in P. carinii does not involve phosphorylation.
3.5. E¡ect of ATP synthesis inhibitors on
2-DOG transport
The mechanisms and properties of the two 2-DOG
transport systems were investigated by probing them
with di¡erent types of inhibitors (Table 2). The oxi-
dase inhibitor salicylhydroxamic acid (SHAM) was
highly e¡ective in reducing 2-DOG uptake, which
is consistent with reports of an active alternative oxi-
dase system in P. carinii [37,39]. Sodium azide,
which was previously shown to signi¢cantly reduce
intracellular ATP levels [37] and cytoplasmic pH in
P. carinii [38], did not inhibit 2-DOG uptake. The
mitochondrial oxidative phosphorylation inhibitors
dinitrophenol (DNP) and KCN were previously
shown to reduce ATP levels in P. carinii [37], and
KCN was reported to also reduce oxygen consump-
tion [40]. These compounds inhibited the high-a⁄n-
ity 2-DOG uptake system, and like azide and
SHAM, this inhibitor had no e¡ect on the low-a⁄n-
ity system. To test the e¡ects of inhibiting ATP pro-
duction via glycolysis, iodoacetate was tested for in-
hibitory activity on 2-DOG uptake. It was previously
reported that iodoacetate strongly inhibited the con-
version of glucose to CO2 by P. carinii [9], but those
studies were performed on organism preparations for
which adequate proof of purity was lacking. Our
results indicated that iodoacetate had only a slight
inhibitory e¡ect on 2-DOG uptake; glucose metabo-
lism was not measured. Thus, glycolysis apparently is
not a major source of ATP used by the organism for
glucose transport. When the combination of iodo-
acetate, KCN, azide, and SHAM was tested, additive
or synergistic e¡ects were not detected. These analy-
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ses on the e¡ects of ATP synthesis inhibitors indicate
that the high-a⁄nity 2-DOG uptake system required
energy from ATP, and that inhibition of the alterna-
tive oxidase pathway was more e¡ective than block-
age of the classical cytochrome-containing electron
transport chain.
3.6. E¡ects of other inhibitors
Cycloheximide and chloramphenicol, classic inhib-
itors of cytosolic and mitochondrial protein synthe-
sis, respectively, were e¡ective in inhibiting protein
synthesis in P. carinii [9]. Organisms pretreated for
10 min with either compound exhibited diminished 2-
DOG uptake by the high-a⁄nity system only (Table
2). When both inhibitors were tested together, an
additive (or perhaps a slightly synergistic) e¡ect
was observed.
Cytochalasin B, an inhibitor of actin polymeriza-
tion, is also a potent inhibitor of the human eryth-
rocyte glucose transporter with a Ki of approx. 0.5
WM [41]. In P. carinii, 2-DOG uptake by the high-
a⁄nity system was more sensitive to cytochalasin B
than was the low-a⁄nity carrier system. However,
the cytochalasin B concentration required to inhibit
2-DOG uptake by P. carinii was more than approx-
imately a thousand times higher than that reported
for mammalian transporters [41] (Table 2). Thus, the
2-DOG transporter in P. carinii is relatively insensi-
tive to this inhibitor compound compared to that
reported for mammalian systems.
It was earlier reported that 8.4 WM of the anti-P.
carinii drug pentamidine inhibited glucose utilization
by 59%, and that the drug also inhibited protein syn-
thesis by 50% at a concentration of 17 WM [9]. In the
present study, 100 WM pentamidine was found to
have no inhibitory e¡ect on 2-DOG uptake by P.
carinii (Table 2). The possibility that pentamidine
inhibits glucose metabolism was not ruled out.
Since hexose and H translocation have been
Table 2
E¡ect of inhibitors and ionophores on 2-DOG uptake by P. carinii
Inhibitors Inhibitor concentration 2-DOG uptake (% of controls)
High-a⁄nity system Low-a⁄nity system
Azide 2 mM 122 þ 21 98 þ 8
SHAM 1 mM 33 þ 4 98 þ 2
Azide+SHAM 2 mM+1 mM 38 þ 1 104 þ 4
2,4-DNP 2 mM 48 þ 1 98 þ 1
KCN 2 mM 69 þ 3 107 þ 2
Iodoacetate 1 mM 72 þ 1 112 þ 1
Iodoacetate+KCN+azide+SHAM 1 mM+2 mM+2 mM+1 mM 36 þ 2 104 þ 2
Cycloheximide 1 mM 52 þ 4 94 þ 5
Chloramphenicol 1 mM 53 þ 2 90 þ 2
Cycloheximide+chloramphenicol 1 mM+1 mM 19 þ 2 97 þ 3
Cytochalasin B 150 WM 58 þ 3 90 þ 4
200 WM 40 þ 2 ND
300 WM ND 62 þ 4
Pentamidine 100 WM 112 þ 13 94 þ 2
CCCP 1 WM 37.1 þ 1.2 ND
10 WM 7.6 þ 0.4 ND
50 WM 3.3 þ 0.3 87 þ 5
DCCD 100 WM 28 þ 2 105 þ 3
Monensin 100 WM 88 þ 10 81 þ 2
150 WM 72 þ 2 ND
300 WM 55 þ 3 83 þ 2
Ouabain 1 mM 75 þ 1 96 þ 11
5 mM 46 þ 2 75 þ 2
10 mM ND 77 þ 3
Organisms were preincubated with compounds then tested for the uptake of 2-DOG. The initial rates of 100 WM and 10 mM 2-DOG
were measured over a 1 min period. Percent of control values are expressed as the means þ S.E.M.; n = 3.
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found to be coupled in several cell types, the proton
ionophore carbonyl cyanide m-chlorophenylhydra-
zone (CCCP) was tested for its e¡ect on 2-DOG
uptake by P. carinii. CCCP has been previously
shown to cause a drop of cytoplasmic pH [38] in
this organism, but the ionophore had no e¡ect on
the uptake of tyrosine, arginine [32], or serine [37].
CCCP was the most potent inhibitor tested in the
present study. At a concentration of only 1 WM, up-
take via the high-a⁄nity 2-DOG transporter was re-
duced by more than 50%. Like CCCP, the plasma
membrane H-ATPase inhibitor N,NP-dicyclohexyl-
carbodiimide (DCCD) was previously shown to de-
crease P. carinii intracellular pH [38], and DCCD
also caused dissipation of the cell membrane poten-
tial [42]. This inhibitor also reduced 2-DOG uptake
by the high-a⁄nity system, suggesting that a trans-
membrane H gradient was needed for glucose up-
take by P. carinii. The e¡ects of DCCD and CCCP
on glucose transport may be the result of disruption
of the proton gradient across the inner mitochondrial
membrane that led to decreased ATP and/or the pro-
ton gradient across the cell surface membrane.
Since symport co-transport of glucose with Na is
common in biological systems, the role of Na on 2-
DOG uptake in P. carinii was investigated. The high-
a⁄nity 2-DOG uptake system was sensitive to both
the (Na-K)-ATPase (NKA) inhibitor, ouabain,
and the Na/H antiport ionophore monensin (Ta-
ble 2). Furthermore, replacement of NaCl in the
bu¡ered incubation solution with equimolar choline
chloride resulted in a marked decrease in 2-DOG
uptake by the high-a⁄nity transporter. After inhibi-
tion in Na-free medium, recovery of the 2-DOG
uptake was Na concentration-dependent (Fig. 2).
The stoichiometry of extracellular Na and 2-DOG
uptake, according to the Hill plot, was 1:1. The re-
sults on testing Na+glucose co-transport by P. ca-
rinii are consistent with the ¢nding of a gene, by ex-
pressed sequence tag (EST) techniques, in the
ongoing Pneumocystis Genome Project, which is ho-
mologous to a gene coding for a low-a⁄nity Na/
glucose transporter (SGLT2) of human kidney cells.
The low-a⁄nity system was not inhibited by removal
of extracellular Na, but may have functioned more
e⁄ciently under those conditions. The uptake of 2-
DOG by the low-a⁄nity high-capacity system in the
Na-free medium was 140 þ 4% of control.
4. Discussion
4.1. Glucose nutritional requirement and uptake
mechanisms in P. carinii
In this report we demonstrate that P. carinii can
take up glucose via two distinct transporter mecha-
nisms. The high-a⁄nity transporter system appears
to require energy from ATP, extracellular Na and a
H gradient across the cell surface membrane. The
reason for inhibition of 2-DOG uptake by ouabain is
not obvious since it binds to the external K-binding
site of the NKA complex within the cell surface
membrane. It appears that unlike cells whose cell
surface membrane potentials are primarily main-
tained by these pumps, the membrane potential
across the cell surface of P. carinii involves a di¡er-
ent mechanism, i.e. a proton gradient. It is not
known whether there is an NKA in the cell surface
membrane of P. carinii, but these results suggest that
the organism has an ouabain-binding NKA, and that
it inhibits 2-DOG uptake as a consequence of re-
duced Na being pumped to the external surface of
the cell. It is not known if the requirement for H is
for maintenance of a proton motive force at the cell
membrane to drive glucose uptake, or if the P. carinii
carrier molecule requires binding of both glucose and
H to function.
By having two glucose transporter systems, the
organism can obtain glucose at optimal rates under
Fig. 2. E¡ects of Na concentration on 2-DOG uptake by P.
carinii. 2-DOG high-a⁄nity transporter (100 WM) was measured
at various sodium concentrations in the incubation medium,
which was altered by isosmotic substitution of NaCl with cho-
line chloride. Values are expressed as means þ S.E.M. of percent
of control (250 þ 22 pmol/mg protein/min); n = 3.
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a broad range of nutrient concentrations in the en-
vironment. When glucose is available in high concen-
trations, both the active transport and facilitated dif-
fusion systems would provide high levels of this
nutrient to the organism. Facilitated di¡usion of glu-
cose is commonly found among diverse organisms,
having been described in human erythrocytes [16],
Trypanosoma cruzi [17], Trypanosoma brucei brucei
bloodstream form [18], Crithidia luciliae [19], Plasmo-
dium falciparum [15] and Saccharomyces cerevisiae
[27]. When the exogenous glucose level is low and
the facilitated di¡usion mechanism is not operation-
al, the high-a⁄nity uphill active transport mecha-
nism would continue providing glucose uptake by
the cells. In P. carinii, this system is linked for sym-
port active transport with Na; which may function
in a similar manner as the glucose+Na systems de-
scribed in intestinal brush border, renal epithelial
cells [20,21], and the bacterium Vibrio parahaemoly-
ticus [22]. Other inhibitors of Na transport, amilor-
ide, benzamil, and dimethyl amiloride, inhibited pro-
liferation of P. carinii short-term culture [43]. It is
not known if the inhibition of glucose transport in
the absence of extracellular Na contributes to the
inhibition of growth of the organism.
H/glucose symport systems have been identi¢ed
in bacteria [10^12,23], Leishmania [29], T. brucei bru-
cei procyclic forms [28], Schizosaccharomyces pombe
[25] and the water fungus Achlya [24]. In Escherichia
coli, it has been shown that melibiose transport re-
quires both Na and H translocation [23]. The re-
sults demonstrating the requirement of the high-af-
¢nity 2-DOG transporter for a H gradient suggest
that the system is directly driven by a proton motive
force at the cell surface, which in turn requires ATP
for the development and maintenance of the trans-
membrane proton gradient.
The glucose requirement for P. carinii growth in
an axenic culture medium is an important ¢nding for
understanding the nature of the organism’s nutrition,
and this also provides insight into the mechanism of
uptake of other nutrients. P. carinii does not take up
serine in the absence of glucose in the medium,
although there was no obvious energy requirement
found for serine uptake. An alternative explanation
was that glucose and serine uptake were linked and
transported by a common carrier system. In the
present study, the ¢nding that serine had no e¡ect
on 2-DOG uptake eliminated the idea of co-trans-
port, thus the in£uence of glucose on amino acid
uptake by P. carinii remains unexplained.
4.2. Comparison of P. carinii and mammalian
GLUT glucose transporters
Analysis of the substrate speci¢city of P. carinii
transport systems showed that hydroxyl groups lo-
cated at positions C-3, C-5 and C-6 are vital for
recognition by the transporters whereas positions
C-2 and C-4 are less important. The P. carinii 2-
DOG uptake systems recognized fructose, which dif-
fers from the mammalian erythrocyte GLUT1 glu-
cose transporter [44]. The mammalian liver glucose
transporter GLUT2 is able to transport fructose but
has only a low a⁄nity for this hexose sugar [45], and
thus di¡ers from the high-a⁄nity 2-DOG uptake sys-
tem of P. carinii. Similar to the Na/glucose co-
transporter of V. parahaemolyticus [22], both P. ca-
rinii 2-DOG uptake systems were inhibited by galac-
tose. In contrast, the mammalian GLUT1 transport-
er exhibited only very low a⁄nity for galactose [44].
It was reported that the renal Na/glucose co-trans-
porter system SGLT2 [46] also has only low a⁄nity
for this sugar. The ability of the P. carinii 2-DOG
uptake systems to interact with fructose and galac-
tose indicates that there are important di¡erences
between glucose carriers in mammals and P. carinii.
Also, the P. carinii 2-DOG uptake systems were far
less sensitive to cytochalasin B compared to GLUT1
[41]. These di¡erences may be targeted for the devel-
opment of new chemotherapeutic approaches for
P. carinii infection.
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